04:03 PM EDT, 04/04/2024 (MT Newswires) -- Health care stocks fell late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each dropping 1.3%.

The iShares Biotechnology ETF (IBB) shed 1.4%.

In corporate news, Paragon 28 ( FNA ) shares tumbled past 15%. The company announced the departure of Chief Financial Officer Stephen Deitsch and projected higher Q1 revenue.

Simulations Plus ( SLP ) surged more than 23% after it said Thursday that the US Food and Drug Administration has renewed its licenses to the company's DILIsym software platform.

ADC Therapeutics ( ADCT ) rose past 6% after the company said it completed dose escalation in its phase 1b trial of Zynlonta plus glofitamab or mosunetuzumab in people with relapsed/refractory B-cell non-Hodgkin lymphoma.

Allurion Technologies ( ALUR ) skyrocketed 74% after the company said it has started commercial US sales of its weight-loss management and patient-monitoring system.